IP Library Granted Patent US 10,150,791
Granted Patent B2
US 10,150,791 · App. 15/425,329 · Granted Dec 11, 2018

Diarylsulfide backbone containing photolabile protecting groups

Inventor: Klaus-Peter Stengele (Pleiskirchen, DE)
Assignee: Roche Diagnostics Operations, Inc.
C07H19/20C07C319/14C07C323/19C07C323/32C07D207/16C07D213/70C07D231/12C07D235/28C07H1/00C07H19/02C07H19/06C07H19/10C07H19/16C07K1/04C07K7/08Y02P20/55
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,150,791
App. No.
15/425,329
Granted
Dec 11, 2018
Kind
B2
Abstract

The present disclosure relates to photoactivable protecting groups containing a diarylsulfide chromophore, a method for the synthesis thereof and their use as photoactivable protecting groups using maskless photolithography based array synthesis.

Claims (19)

1. A compound of the formula

wherein Y is S, and

A is selected from the group consisting of CH 2 , —CH 2 —CH 2 —, —CH(CH 3 )—, —CH(CH 3 )—CH 2 —, and

R1 is an unsubstituted or substituted aryl- or heteroaryl-group, and R3 is H, a methyl group or an ethyl group, and

wherein R2 is

or wherein R2 is

wherein R4 is H, forms a phosphoramidite, H-phosphonate or phosphate triester, and

wherein R5 is H, OH, a halogen or XR6, wherein X is O or S and R6 is H, an alkyl-group, aryl-group, or OR6 forms a phosphoramidite, phosphodiester, phosphotriester, H-phosphonate or an acetal or silicone moiety, and

wherein B is selected from the group consisting of adenine, cytosine, guanine, thymine, uracil, 2,6-diaminopurine-9-yl, hypoxanthin-9-yl, 5-methylcytosinyl-1-yl, 5-amino-4-imidazolecarboxylic acid-1-yl or 5-amino-4-imidazolecarboxylic acid amide-3-yl, wherein when B is adenine, cytosine or guanine the primary amino group optionally has a protecting group or when B is thymine or uracil at the O 4 position is optionally a protecting group, or

wherein R 2 is

wherein R7 is a natural amino acid, a non-natural amino acid or an amino acid derivative.

2. The compound according to claim 1 wherein R1 is a phenyl-group, a tert-butyl-phenyl group, a 1- or 2-naphthyl-group, a 2-pyridyl-group.

3. The compound according to claim 1 wherein A is —CH(CH 3 )—CH 2 —.

4. The compound according to claim 1 wherein R3 is H or an ethyl group.

5. The compound according to claim 1 wherein R4 is H and R5 is H.

6. The compound according to claim 1 wherein B is selected from the group consisting of adenine, cytosine, guanine, thymine or uracil.

7. The compound according to claim 1 wherein when B is adenine, cytosine or guanine the protecting group is phenoxyacetyl-, 4-tert-butyl-phenoxyacetyl-, 4-isopropyl-phenoxyacetyl- or dimethylformamidino-residues, when B is adenine the protecting group is benzoyl- or p-nitro-phenyl-ethoxy-carbonyl- (p-NPPOC)-residues, when B is guanine the protecting group is isobutyroyl-, p-nitrophenylethyl (p-NPE) or p-NPEOC-residues and when B is cytosine the protecting group is benzoyl-, isobutyryl- or p-NPEOC-residues.

8. The compound according to claim 1 wherein R7 is a natural amino acid.

9. The compound of claim 1 wherein Y is S; A is —CH(CH 3 )CH 2 —; R1 is phenyl, tert-butyl-phenyl, 1- or 2-naphtyl or 2-pyridyl; and R3 is H or ethyl.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 15, 2017
From: STENGELE, KLAUS-PETER
To: NIMBLEGEN SYSTEMS GMBH
Reel/Frame 041258/0513 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 15, 2017
From: ROCHE DIAGNOSTICS GMBH
To: ROCHE DIAGNOSTICS OPERATIONS, INC.
Reel/Frame 041258/0739 →
MERGER Recorded Feb 15, 2017
From: NIMBLEGEN SYSTEMS GMBH
To: ROCHE DIAGNOSTICS GMBH
Reel/Frame 041719/0133 →
Priority Claims (1)
EP 11161556 · Apr 7, 2011 · regional
Continuity (4)
Continuation 14935516 · Nov 9, 2015
Continuation 14061297 · Oct 23, 2013
Continuation 13433373 · Mar 29, 2012
Related Publication 20170145047A1 · May 25, 2017
Cited By (1)
US 12,624,392